DAXXIFY (daxibotulinumtoxinA-lanm)
NEUROMUSCULAR BLOCKERS · SPASMODIC TORTICOLLIS ·+1
REVANCE THERAPE
Drug class
Neuromuscular Blocker - Neurotoxins
Neuromuscular blocker neurotoxins—principally comprising pharmaceutical formulations of botulinum toxin serotypes—are biologic agents that act as localized acetylcholine release inhibitors. Read more about Neuromuscular Blocker - Neurotoxins
12 drugs in this class 11 manufacturers
Drugs in Neuromuscular Blocker - Neurotoxins
BOTOX COSMETIC (onabotulinumtoxinA)
NEUROMUSCULAR BLOCKERS · GLABELLAR LINES ·+3
Allergan
LETYBO (letibotulinumtoxinA-wlbg)
NEUROMUSCULAR BLOCKERS · GLABELLAR LINES
HUGEL, INC.
Filter & compare in the drug finder →
Opens the drug finder with Neuromuscular Blocker - Neurotoxins preselected. Add indication or manufacturer filters there.
Neuromuscular blocker neurotoxins—principally comprising pharmaceutical formulations of botulinum toxin serotypes—are biologic agents that act as localized acetylcholine release inhibitors.
By enzymatically cleaving SNARE complex proteins in presynaptic motor and autonomic nerve terminals, they prevent vesicular exocytosis of acetylcholine, producing a targeted, temporary flaccid chemical denervation at the neuromuscular junction.
In therapeutic practice, these agents are indicated for neurological and musculoskeletal conditions characterized by muscle hyperactivity, including cervical dystonia, upper and lower limb spasticity, blepharospasm, and chronic migraine prophylaxis.
They are also widely utilized for focal autonomic and urologic disorders such as severe primary axillary hyperhidrosis and neurogenic detrusor overactivity, as well as for aesthetic reduction of dynamic facial rhytids.
-
fda.gov
Neuromuscular blocker neurotoxins—principally comprising pharmaceutical formulations of botulinum toxin serotypes—are biologic agents that act as localized acetylcholine release inhibitors By enzymatically cleaving SNARE complex proteins in presynaptic motor and autonomic nerve terminals, they prevent vesicular exocytosis of acetylcholine, producing a targeted, temporary flaccid chemical denervation at the neuromuscular junction In therapeutic practice, these agents are indicated for neurologica...
-
nih.gov
Neuromuscular blocker neurotoxins—principally comprising pharmaceutical formulations of botulinum toxin serotypes—are biologic agents that act as localized acetylcholine release inhibitors In therapeutic practice, these agents are indicated for neurological and musculoskeletal conditions characterized by muscle hyperactivity, including cervical dystonia, upper and lower limb spasticity, blepharospasm, and chronic migraine prophylaxis
-
wikipedia.org
By enzymatically cleaving SNARE complex proteins in presynaptic motor and autonomic nerve terminals, they prevent vesicular exocytosis of acetylcholine, producing a targeted, temporary flaccid chemical denervation at the neuromuscular junction
-
nih.gov
In therapeutic practice, these agents are indicated for neurological and musculoskeletal conditions characterized by muscle hyperactivity, including cervical dystonia, upper and lower limb spasticity, blepharospasm, and chronic migraine prophylaxis They are also widely utilized for focal autonomic and urologic disorders such as severe primary axillary hyperhidrosis and neurogenic detrusor overactivity, as well as for aesthetic reduction of dynamic facial rhytids
-
fda.gov
They are also widely utilized for focal autonomic and urologic disorders such as severe primary axillary hyperhidrosis and neurogenic detrusor overactivity, as well as for aesthetic reduction of dynamic facial rhytids
-
drugs.com
They are also widely utilized for focal autonomic and urologic disorders such as severe primary axillary hyperhidrosis and neurogenic detrusor overactivity, as well as for aesthetic reduction of dynamic facial rhytids
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.